Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis

Human Pathology

Volumn 37, Issue 12, 2006, Pages 1568-1576

  Shariat, Shahrokh F ^a   Ashfaq, Raheela ^a   Sagalowsky, Arthur I ^a   Lotan, Yair ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cyclin D1; Cyclin E1; p21; p27; p53; Retinoblastoma; Transitional cell carcinoma

Indexed keywords

CYCLIN D1; CYCLIN E1; PROTEIN; PROTEIN P21; PROTEIN P27; PROTEIN P53; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BLADDER CANCER; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; CORRELATION ANALYSIS; CYSTECTOMY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; STATISTICAL SIGNIFICANCE; TRANSITIONAL CELL CARCINOMA; UROTHELIUM;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CELL CYCLE PROTEINS; CYCLIN E; CYCLINS; CYSTECTOMY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; ONCOGENE PROTEINS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 33751208922     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2006.05.017     Document Type: Article

References (25)

1. Hanahan D., and Weinberg R.A. The hallmarks of cancer. Cell 100 (2000) 57-70
2. Sherr C.J., and Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13 (1999) 1501-1512
3. Sgambato A., Migaldi M., Faraglia B., et al. Cyclin D1 expression in papillary superficial bladder cancer: its association with other cell cycle-associated proteins, cell proliferation and clinical outcome. Int J Cancer 97 (2002) 671-678
4. Niehans G.A., Kratzke R.A., Froberg M.K., Aeppli D.M., Nguyen P.L., and Geradts J. G1 checkpoint protein and p53 abnormalities occur in most invasive transitional cell carcinomas of the urinary bladder. Br J Cancer 80 (1999) 1175-1184
5. Richter J., Wagner U., Kononen J., et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 157 (2000) 787-794
6. Del Pizzo J.J., Borkowski A., Jacobs S.C., and Kyprianou N. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival. Am J Pathol 155 (1999) 1129-1136
7. Kamai T., Takagi K., Asami H., Ito Y., Oshima H., and Yoshida K.I. Decreasing of p27(Kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer. Br J Cancer 84 (2001) 1242-1251
8. Ioachim E., Michael M., Stavropoulos N.E., et al. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Urol Int 73 (2004) 65-73
9. Lopez-Beltran A., Luque R.J., Alvarez-Kindelan J., et al. Prognostic factors in survival of patients with stage Ta and T1 bladder urothelial tumors: the role of G1-S modulators (p53, p21Waf1, p27Kip1, cyclin D1, and cyclin D3), proliferation index, and clinicopathologic parameters. Am J Clin Pathol 122 (2004) 444-452
10. Shariat S.F., Weizer A.Z., Green A., et al. Prognostic value of p53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder. Urology 56 (2000) 735-740
11. Shariat S.F., Kim J., Raptidis G., Ayala G.E., and Lerner S.P. Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder. Urology 61 (2003) 1140-1145
12. Chatterjee S.J., Datar R., Youssefzadeh D., et al. Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma. J Clin Oncol 22 (2004) 1007-1013
13. Esrig D., Spruck III C.H., Nichols P.W., et al. p53 nuclear protein accumulation correlates with mutations in the p53 gene, tumor grade, and stage in bladder cancer. Am J Pathol 143 (1993) 1389-1397
14. Cordon-Cardo C., Dalbagni G., Saez G.T., et al. p53 mutations in human bladder cancer: genotypic versus phenotypic patterns. Int J Cancer 56 (1994) 347-353
15. Benedict W.F., Lerner S.P., Zhou J., Shen X., Tokunaga H., and Czerniak B. Level of retinoblastoma protein expression correlates with p16 (MTS-1/INK4A/CDKN2) status in bladder cancer. Oncogene 18 (1999) 1197-1203
16. Shariat S.F., Tokunaga H., Zhou J., et al. p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer. J Clin Oncol 22 (2004) 1014-1024
17. Lotan Y., Gupta A., Shariat S.F., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 23 (2005) 6533-6539
18. Bircan S., Candir O., and Serel T.A. Comparison of WHO 1973, WHO/ISUP 1998, WHO 1999 grade and combined scoring systems in evaluation of bladder carcinoma. Urol Int 73 (2004) 201-208
19. Schraml P., Bucher C., Bissig H., et al. Cyclin E overexpression and amplification in human tumours. J Pathol 200 (2003) 375-382
20. Spruck C.H., Won K.A., and Reed S.I. Deregulated cyclin E induces chromosome instability. Nature 401 (1999) 297-300
21. Juan G., and Cordon-Cardo C. Intranuclear compartmentalization of cyclin E during the cell cycle: disruption of the nucleoplasm-nucleolar shuttling of cyclin E in bladder cancer. Cancer Res 61 (2001) 1220-1226
22. Ohtsubo M., and Roberts J.M. Cyclin-dependent regulation of G1 in mammalian fibroblasts. Science 259 (1993) 1908-1912
23. Quelle D.E., Ashmun R.A., Shurtleff S.A., et al. Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts. Genes Dev 7 (1993) 1559-1571
24. Loden M., Stighall M., Nielsen N.H., et al. The cyclin D1 high and cyclin E high subgroups of breast cancer: separate pathways in tumorogenesis based on pattern of genetic aberrations and inactivation of the pRb node. Oncogene 21 (2002) 4680-4690
25. Hwang H.C., and Clurman B.E. Cyclin E in normal and neoplastic cell cycles. Oncogene 24 (2005) 2776-2786